Physician profile
Susan L Haskell
NPI 1821091877
$860.08
in general payments reported to CMS, 2019-2025
14 companies · $96.96 in 2025
The $96.96 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $71.23 · 2022: $13.58 · 2023: $187 · 2024: $273 · 2025: $96.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $222.12 | 2019-2025 | Cequa |
| Biotissue Holdings INC. | $153.87 | 2024 | |
| Alcon Vision LLC | $103.55 | 2019-2025 | Precision 1, Precision7 |
| Novartis Pharmaceuticals Corporation | $69.24 | 2019-2023 | |
| Sight Sciences, INC. | $61.67 | 2019-2024 | Tearcare System |
| Coopervision INC. | $52.14 | 2020 | |
| Bausch & Lomb Americas INC. | $45.88 | 2024 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.70 | 2019 | |
| Oyster Point Pharma, INC. | $32.53 | 2023 | Tyrvaya |
| Visioneering Technologies, INC. | $21.96 | 2019 | |
| Abbvie INC. | $20.28 | 2025 | |
| Allergan, INC. | $18.42 | 2019 | |
| Shire North American Group INC | $11.82 | 2019 | |
| Quidel Corporation | $9.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Haskell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.